The estimated Net Worth of Steven M Odre is at least $27.8 Million dollars as of 27 January 2004. Steven Odre owns over 7,572 units of AMGEN stock worth over $27,809,724 and over the last 21 years Steven sold AMGN stock worth over $0.
Steven has made over 2 trades of the AMGEN stock since 2003, according to the Form 4 filled with the SEC. Most recently Steven exercised 7,572 units of AMGN stock worth $107,068 on 27 January 2004.
The largest trade Steven's ever made was exercising 15,000 units of AMGEN stock on 21 November 2003 worth over $212,100. On average, Steven trades about 7,524 units every 22 days since 2003. As of 27 January 2004 Steven still owns at least 84,277 units of AMGEN stock.
You can see the complete history of Steven Odre stock trades at the bottom of the page.
Steven's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer und Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: